EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Repeated Intrathecal Stem Cells Optimize Neuroplasticity and Motor Function in Moderate‐to‐Severe Cerebral Palsy of Rats

Yi Xu, Ting–Ting Peng, Shiya Huang, Xiaolin Guo, Jie Luo, Tingting Peng, Liru Liu, Mingshan Han, Ting Gao, Hongmei Tang, Jing Zhang, Lu He, Kaishou Xu

Stem Cells International · 2025-01 · 2025 (1)

DOI: 10.1155/sci/4337435 ↗
AbstractBibliografische Angaben

Abstract

Human umbilical cord‐derived mesenchymal stem cells (hUC‐MSCs) ameliorate motor deficits in cerebral palsy (CP), but the effect of injection frequency remains unclear. Moreover, most studies have focused on mild CP models (unilateral carotid artery occlusion [UCAO] model). This study explored the effect and mechanism of hUC‐MSCs in a rat model of moderate‐to‐severe CP (bilateral carotid artery occlusion [BCAO] model). On postnatal Day 4 (P4), Wistar rat pups underwent BCAO induction. Subsequently, they received either a single intrathecal injection of hUC‐MSCs on P21 or repeated injections on P21, P28, P35, and P42. Motor performance was assessed using the rotarod and front‐limb suspension tests, while neuronal regeneration and inflammation were evaluated via biomarkers including neuronal nuclear antigen (NeuN), ionized calcium‐binding adapter molecule‐1 (Iba‐1), glial fibrillary acidic protein (GFAP), myelin basic protein (MBP), and brain‐derived neurotrophic factor (BDNF). P18 model screening confirmed that the BCAO model resulted in more severe brain damage and motor impairment than the UCAO model. After injection of lentivirally transfected hUC‐MSCs, it was found that hUC‐MSCs could nest in the damaged area and survive for at least 3 days. Administration of hUC‐MSCs following BCAO modeling led to notable improvements in both behavioral performance and histological outcomes. Furthermore, repeated injections offered greater therapeutic benefits compared to single injection. It indicated that the efficacy of repeated injections of hUC‐MSCs in the treatment of moderate‐to‐severe CP was superior to that of single injection. Its mechanism was related to the improvement of damaged myelin structure, reduced immunoinflammatory responses, and increased neurotrophic support.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →